BridgeBio Pharma (BBIO) Other Non-Current Liabilities (2018 - 2026)
BridgeBio Pharma's Other Non-Current Liabilities came in at $240,000 for Q2 2026, down 56.0% from $545,000 a year earlier but up 4.8% from the prior quarter.
BridgeBio Pharma (BBIO) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma's Other Non-Current Liabilities was $244,000, down 14.7% from FY2024.
- Other Non-Current Liabilities has declined in each of the last three years, with a five-year compound annual growth rate of -51.9% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $286,000 in FY2024 (-94.9%), $5.63 million in FY2023 (-78.9%), $26.64 million in FY2022 (+20.7%) and $22.07 million in FY2021 (+131.8%).
- The five-year range for quarterly Other Non-Current Liabilities is $229,000 (Q1 2026) to $28.63 million (Q2 2022).
- Year-over-year, Other Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 30.7% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q4 2021 (growth of 131.8%), and the weakest in Q3 2024 (a decline of 96.8%).
- Business Quant data shows BBIO's Other Non-Current Liabilities at $229,000 (Q1 2026), $244,000 (Q4 2025) and $679,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | BridgeBio Pharma | 13.26 Bn | 10.37 Bn | 228.63 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 679,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 352,000.00 |
| Dec 31, 2024 | 286,000.00 |
| Sep 30, 2024 | 377,000.00 |
| Jun 30, 2024 | 485,000.00 |
| Mar 31, 2024 | 595,000.00 |
| Dec 31, 2023 | 5.63 Mn |
| Sep 30, 2023 | 11.79 Mn |
| Jun 30, 2023 | 13.33 Mn |
| Mar 31, 2023 | 17.50 Mn |
| Dec 31, 2022 | 26.64 Mn |
| Sep 30, 2022 | 28.23 Mn |
| Jun 30, 2022 | 28.63 Mn |
| Mar 31, 2022 | 26.83 Mn |
| Dec 31, 2021 | 22.07 Mn |
| Sep 30, 2021 | 27.58 Mn |
BridgeBio Pharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();